Effects of Mindfulness Meditation Training on Anxiety and Sleep Quality of Patients With Hematopoietic Stem Cell Transplantation During Admission in the Laminar Flow Chamber
1 other identifier
observational
70
1 country
1
Brief Summary
In recent years, it has been widely observed that patients undergoing hematopoietic stem cell transplantation often experience elevated anxiety levels and a decline in sleep quality during their stay in the laminar flow chamber. Existing psychological support measures have proven insufficient in addressing their specific needs. Consequently, there is a pressing need to explore safe, non-pharmacological interventions suitable for this isolated clinical environment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Mar 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2025
CompletedFirst Submitted
Initial submission to the registry
March 2, 2026
CompletedFirst Posted
Study publicly available on registry
March 10, 2026
CompletedMarch 10, 2026
March 1, 2026
3 months
March 2, 2026
March 6, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Effect of the mindfulness meditation practice on the PSQI
· Before and after the intervention, the Pittsburgh Sleep Quality Index Scale (PSQI) was used to measure the two groups. Each component was weighted equally on a 0 to 3 scale and summed to provide a one-factor global PSQI score ranging from 0 (no sleep problems) to 21 (severe sleep problems) with scores \> 5 considered indicative of 'problem sleep' according to the original validation and scoring reference
Day 1; Up to 4 weeks
Secondary Outcomes (1)
Effect of the mindfulness meditation practice on the SAS
Day 1; Up to 4 weeks
Study Arms (2)
control group
Provide routine health education and transplant care before and after admission. During pretreatment, as blood cell counts drop, offer oral, skin, and perianal care. Guide hand hygiene throughout to prevent infection. During stem cell transfusion, monitor vital signs closely. During recovery, guide patients on safety, rest, and activity. Explain HSCT-related knowledge and provide psychological and social support.
Intervention group
Meditation training included two stages. Stage 1: 7-Day Course Goal: Build trust, explain the study, and teach meditation. Body Relaxation (5 min): Patients closed eyes and relaxed from head to toes, guided by a qualified intervener. Breathing Adjustment (5 min): Patients focused on slow breaths and abdominal movement; if distracted, they refocused calmly. Attention Focus (20 min): Patients imagined recovery scenes, like post-transplant renewal, guided by vivid descriptions. Stage 2: 21-Day Self-Practice (Days 1-21 post-transplant) Patients meditated daily for one hour before sleep, guided by soothing music, and kept a log. Nursing staff recorded sessions, addressed issues, and tracked progress.
Interventions
Mindfulness meditation is a cognitive-behavioral practice that enhances self-regulatory capacity through attentional control and emotional regulation, promoting psychophysiological homeostasis characterized by mental calmness and focused awareness. This non-invasive intervention demonstrates operational feasibility with minimal implementation barriers, owing to its non-pharmacological nature, absence of documented adverse effects, and cost-effectiveness. It improves both affective and sleep outcomes in diverse oncology populations
Eligibility Criteria
(1) Patients with secondary transplantation, (2) Patients with other critical illness, such as malignancy, cardiac failure, renal failure, respiratory failure, severe traum, (3) patients with mental illness or psychotherapy before admission.
You may qualify if:
- Age 18 years
- HSCT
- Volunteered to join the study
You may not qualify if:
- Patients with secondary transplantation
- Patients with other critical illness, such as malignancy, cardiac failure, renal failure, respiratory failure, severe traum
- Patients with mental illness or psychotherapy before admission
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Henan Universitylead
Study Sites (1)
Henan University
Kaifeng, Henan, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 2, 2026
First Posted
March 10, 2026
Study Start
March 1, 2025
Primary Completion
June 1, 2025
Study Completion
June 1, 2025
Last Updated
March 10, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share